. 2020 Oct 14;11(12):2374–2381. doi: 10.1021/acsmedchemlett.0c00255

Table 4. Percentage Inhibitions Measured for Key Compounds in Table 3 against Different Kinases in-House.

	FLT3		CDK2		AURA		GSK3B		MUSK
ID	0.1 μM^a	1.0 μM^a	0.1 μM^a	1.0 μM^a	0.1 μM^a	1.0 μM^a	0.1 μM^a	1.0 μM^a	0.1 μM^a	1.0 μM^a
19	87	94	44	81	3	19	46	86	14	28
22	82	92	20	69	0	13	47	84	13	18
24	42	70	0	10	0	0	0	6	0	4
25	34	64	9	15	6	5	12	16	7	10

Indicates compound concentration.